XML 67 R21.htm IDEA: XBRL DOCUMENT v3.20.1
Balance Sheet Components (Tables)
3 Months Ended
Mar. 31, 2020
Organization Consolidation And Presentation Of Financial Statements [Abstract]  
Summary of Gross Unrealized Gains and Unrealized Losses of Investment Securities Excluding Investments in Money Market Funds The following is a summary of the gross unrealized gains and unrealized losses on the Company’s investment securities, excluding investments in money market funds (in thousands):

 

 

 

March 31, 2020

 

 

 

Amortized

Cost

 

 

Gross

Unrealized

Holding

Gains

 

 

Gross

Unrealized

Holding

Losses

 

 

Aggregate

Fair Value

 

Investment Securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Agency bonds

 

$

12,972

 

 

$

95

 

 

$

 

 

$

13,067

 

Commercial paper (i)

 

 

74,354

 

 

 

10

 

 

 

(1

)

 

 

74,363

 

Corporate notes (i)

 

 

83,155

 

 

 

40

 

 

 

(152

)

 

 

83,043

 

Total securities

 

$

170,481

 

 

$

145

 

 

$

(153

)

 

$

170,473

 

 

 

December 31, 2019

 

 

 

Amortized

Cost

 

 

Gross

Unrealized

Holding

Gains

 

 

Gross

Unrealized

Holding

Losses

 

 

Aggregate

Fair Value

 

Investment Securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Agency bonds

 

$

17,209

 

 

$

37

 

 

$

 

 

$

17,246

 

Commercial paper

 

$

12,425

 

 

$

24

 

 

$

 

 

 

12,449

 

Corporate notes

 

 

142,588

 

 

 

150

 

 

 

(4

)

 

 

142,734

 

Total securities

 

$

172,222

 

 

$

211

 

 

$

(4

)

 

$

172,429

 

 

 

(i)

Includes $50.0 million of commercial paper and $9.3 million of corporate notes that is classified as cash and cash equivalents on the condensed consolidated balance sheets.

Summary of Contractual Maturities of Investment Securities

The contractual maturities of the Company’s investment securities as of March 31, 2020 were as follows (in thousands):

 

 

 

Amortized Cost

 

 

Fair Value

 

Amounts maturing within one year

 

$

170,481

 

 

$

170,473

 

Amounts maturing after one year through five years

 

 

 

 

 

 

Total investment securities

 

$

170,481

 

 

$

170,473

 

Components of Inventories

Inventories (in thousands)

 

 

 

March 31,

 

 

December 31,

 

 

 

2020

 

 

2019

 

Raw materials

 

$

22,751

 

 

$

26,354

 

Finished goods

 

 

70,232

 

 

 

65,225

 

Total inventories

 

$

92,983

 

 

$

91,579

 

Schedule of Property and Equipment, Net and Depreciation and Amortization Expense

Property and Equipment, Net (in thousands)

 

 

 

March 31,

 

 

December 31,

 

 

 

2020

 

 

2019

 

Laboratory equipment

 

$

5,841

 

 

$

5,733

 

Computer equipment and software

 

 

10,281

 

 

 

9,909

 

Furniture and fixtures

 

 

3,918

 

 

 

3,898

 

Leasehold improvements

 

 

4,226

 

 

 

4,226

 

Construction in process

 

 

1,169

 

 

 

1,006

 

Total

 

 

25,435

 

 

 

24,772

 

Less: Accumulated depreciation and amortization

 

 

(14,274

)

 

 

(13,006

)

Property and equipment, net

 

$

11,161

 

 

$

11,766

 

The Company recognized depreciation and amortization expense on property and equipment as follows (in thousands):

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2020

 

 

2019

 

Depreciation and amortization expense

 

$

1,296

 

 

$

1,085

 

Summary of Accrued Liabilities

Accrued Liabilities (in thousands)

 

 

 

March 31,

 

 

December 31,

 

 

 

2020

 

 

2019

 

Accrued payroll and related expenses

 

$

22,738

 

 

$

36,056

 

Accrued professional fees

 

 

2,041

 

 

 

1,633

 

Accrued taxes

 

 

2,117

 

 

 

2,353

 

Accrued clinical and research expenses

 

 

1,716

 

 

 

2,157

 

Accrued interest

 

 

998

 

 

 

243

 

Accrued warranty

 

 

1,192

 

 

 

1,178

 

Accrued other

 

 

6,535

 

 

 

7,346

 

Total accrued liabilities

 

$

37,337

 

 

$

50,966